Mucosal leishmaniasis: Quantitative nasal cytology as a marker of disease activity and indicator of healing

Annals of Otology, Rhinology and Laryngology

Volumn 109, Issue 1, 2000, Pages 89-94

  Guerreiro, Jaqueline B ^a   Lessa, Hélio A ^a   Cruz, Álvaro A ^a   Rocha, Heonir ^a   Barral, Aldina ^a   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Leishmaniasis; Mucosal leishmaniasis; Nasal cytology

Indexed keywords

ANTIMONY; MEGLUMINE ANTIMONATE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC VALUE; DISEASE ACTIVITY; EPITHELIUM CELL; FEMALE; FOLLOW UP; HEALING; HUMAN; HUMAN TISSUE; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; MALE; NEUTROPHIL; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TREATMENT OUTCOME;

EID: 0342980308     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940010900117     Document Type: Article

References (18)

1. Ashford RW, Desfeux P, Racedt P. Estimations of population at risk of infection and number of cases of leishmaniasis. Parasilol Today 1992;8:105.
2. Carvalho EM, Johnson WD, Barreto E, et al. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol 1985;135:4144-8.
3. Zajtchuk JT, Casler JD, Netto EM, et al. Mucosal leishmaniasis in Brazil. Laryngoscope 1989;99:925-39.
4. Mardsen PD. Mucosal leishmaniasis. ("Espundia" or escomel). Trans R Soc Trop Med Hyg 1986;80:859-67.
5. Barral-Netto M, Machado P, Barral A. Human cutaneous leishmaniasis. Recent advances in physiopathology and treatment. Eur J Dermatol 1995;5:104-13.
6. Cuba CAC, Llanos-Cuentas EA, Barreto AC, et al. Human mucocutaneous leishmaniasis in Três Braços, Bahia, Brazil. An area of transmission. I. Laboratory diagnosis. Rev Soc Bras Med Trop 1984;17:161-7.
7. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pre-treatment. Am Rev Respir Dis 1988;138:406-12.
8. Cruz AA, Darze ES, Santos RS, Barral A, Carvalho EM. Preliminary evaluation of a quantitative method of nasal cytology for clinical purposes [Abstract]. Allergy 1993;48:60.
9. Reed SG, Badaro R, Mansur H, et al. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg 1986;35:79-85.
10. Barral A, Pedral-Sampaio D, Grimaldi G Jr, et al. Leishmaniasis in Bahia-Brazil. Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 1991;44:536-46.
11. Cruz AA, Naclerio RM, Lichtenstein LM, Kagey-Sobotka A, Proud D, Togias AG. Epithelial cell detachment is observed during the nasal reaction to cold dry air [Abstract]. J Allergy Clin Immunol 1991;87:A147.
12. Baroody FM, Cruz AA, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol 1992;90:373-6.
13. Lim MC, Taylor RM, Naclerio RM. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavages. Am J Respir Crit Care Med 1995;151:136-44.
14. Murray HW, Rubin BY, Rothermel CD. Killing of lymphokine-stimulated human mononuclear phagocytes: evidence that interferon gamma is the activating cytokine. J Clin Invest 1983;72:1506-13.
15. Carvalho EM, Barral A, Pedral-Sampaio D, et al. Immunologic markers of clinical evalution in children recently infected with Leishmania donovani chagasi. J Infect Dis 1992; 165:535-40.
16. Castes M, Trujillo D, Rojas ME, et al. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol Res 1993;26:223-8.
17. Da Cruz AM, Oliveira MP, De Luca PM, Mendonça SCF, Coutinho SG. Tumor necrosis factor in human American tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 1986;91:225-9.
18. Caceres-Ditimar G, Tapia FJ, Sanchez MA, et al. Determination of the cytokine profile in American cutaneous leishmaniasis using polymerase chain reaction. Clin Exp Immunol 1993; 91:500-5.